<- Go Home
CepTor Corporation
CepTor Corporation, a biopharmaceutical company, focuses on the development of cell-targeted therapeutic products for neuromuscular and neurodegenerative diseases. It also develops products for multiple sclerosis, retinal degeneration, and epilepsy. CepTor Corporation was formerly known as Medallion Crest Management Inc. and changed its name to CepTor Corporation in December 2004. The company was founded in 1986 and is based in Hunt Valley, Maryland.
Market Cap
$24.9K
Volume
55.2K
Cash and Equivalents
$1.3K
EBITDA
-$824.0K
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$0.01
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
-0.00
Price / Earnings
0.00
Price / Tangible Book Value
-0.00
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$843.1K
Return on Equity
68.30%
Return on Assets
-55.51
Cash and Short Term Investments
$1.3K
Debt
$5.9M
Equity
-$11.8M
Revenue
N/A
Unlevered FCF
-$17.9M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium